Zinc-pheophorbide a-Highly efficient low-cost photosensitizer against human adenocarcinoma in cellular and animal models

Photodiagnosis and Photodynamic Therapy

Volumn 10, Issue 3, 2013, Pages 266-277

  Jakubowska, Monika ^a   Szczygieł, Małgorzata ^a   Michalczyk Wetula, Dominika ^a   Susz, Anna ^a   Stochel, Grazyna ^a   Elas, Martyna ^a   Fiedor, Leszek ^a   Urbanska, Krystyna ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Human adenocarcinoma; Photodynamic therapy; Zn pheophorbide

Indexed keywords

CHLOROPHYLL; PHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG; ZINC; ZINC PHEOPHORBIDE A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; COST; CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MALE; MITOCHONDRION; MOUSE; NONHUMAN; NUDE MOUSE; PHOTODYNAMIC THERAPY; PHOTODYNAMICS; PHOTOTOXICITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ANIMALIA; MUS MUSCULUS;

HUMAN ADENOCARCINOMA; PHOTODYNAMIC THERAPY; ZN-PHEOPHORBIDE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; CHLOROPHYLL; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TREATMENT OUTCOME; ZINC;

EID: 84883445565     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2012.12.004     Document Type: Article

References (58)

1. Brandis A., Salomon Y., Scherz A. Chlorophyll sensitizers in photodynamic therapy. Chlorophylls and bacteriochlorophyls: biochemistry, biophysics, functions and applications 2006, 462-483. Springer, Dordrecht. B. Grimm, R. Porra, W. Rudiger, H. Scheer (Eds.).
2. Juarranz A., Jaen P., Sanz-Rodriguez F., Cuevas J., Gonzalez S. Photodynamic therapy of cancer, basic principles and applications. Clinical and Translational Oncology 2008, 10:148-154.
3. Yano S., Hirohara S., Obata M., Hagiya Y., Ogura S.-i., Ikeda A., et al. Current states and future views in photodynamic therapy. Journal of Photochemistry and Photobiology C: Photochemistry Reviews 2011, 12:46-67.
4. Agostinis P., Berg K., Cengel K.A., Foster T.H., Girotti A.W., Gollnick S.O., et al. Photodynamic therapy of cancer: an update. CA: A Cancer Journal for Clinicians 2011, 61:250-281.
5. Hasan T.B., Ortel B., Moor A.C.E., Pogue B.W. Photodynamic therapy of cancer. Holland-Frei cancer medicine 2003, 605-622. Decker Publishing Inc., Hamilton. D.W. Kufe, R.E. Pollock, R.R. Weichselbaum, R.C. Bast, T.S. Gansler, J.F. Holland, E. Frei (Eds.).
6. Pandey R.K., Goswami L.N., Chen Y., Gryshuk A., Missert J.R., Oseroff A., et al. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers in Surgery and Medicine 2006, 38:445-467.
7. Preise D., Scherz A., Salomon Y. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP). Photochemistry and Photobiology Science 2011, 10:681-688.
8. Fiedor L., Gorman A., Hamblett I., Rosenbach-Belkin V., Salomon Y., Scherz A., et al. A pulsed laser and pulse radiolysis study of amphiphilic chlorophyll derivatives with PDT activity toward malignant melanoma. Photochemistry and Photobiology 1993, 58:506-511.
9. Fiedor J., Fiedor L., Winkler J., Scherz A., Scheer H. Photodynamics of the bacteriochlorophyll-carotenoid system 1. Bacteriochlorophyll-photosensitized oxygenation of b-carotene in acetone. Photochemistry and Photobiology 2001, 74:64-71.
10. Spikes J.D., Bommer J.C. Chlorophyll and related pigments as photosensitizers in biology and medicine. Chlorophylls 1991, 1181-1204. CRC Press, Boca Raton. H. Scheer (Ed.).
11. Henderson B.W., Sumlin A.B., Owczarczak B.L., Dougherty T.J. Bacteriochlorophyll-a as photosensitizer for photodynamic treatment of transplantable murine tumors. Journal of Photochemistry and Photobiology 1991, 10:303-313.
12. Fiedor L., Rosenbach-Belkin V., Sai M., Scherz A. Preparation of tetrapyrole-amino acid covalent complex. Plant Physiology and Biochemistry 1996, 34:393-398.
13. Hartwich G., Fiedor L., Simonin I., Cmiel E., Schäfer W., Noy D., et al. Metal-Substituted Bacteriochlorophylls 1. Preparation and Influence of Metal and Coordination on Spectra. Journal of the American Chemical Society 1998, 120:3675-3683.
14. Drzewiecka-Matuszek A., Skalna A., Karocki A., Stochel G., Fiedor L. Effects of heavy central metal on the ground and excited states of chlorophyll. Journal of Biological Inorganic Chemistry 2005, 10:453-462.
15. Koudinova N.V., Pinthus J.H., Brandis A., Brenner O., Bendel P., Ramon J., et al. Photodynamic therapy with Pd-bacteriopheophorbide (Tookad): successful in vivo treatment of human prostatic small cell carcinoma xenographs. International Journal of Cancer 2003, 104:782-789.
16. Weersink R.A., Bogaards A., Gertner M., Davidson S.R., Zhang K., Netchev G., et al. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities. Journal of Photochemistry and Photobiology B 2005, 79:211-222.
17. Davidson S.R., Weersink R.A., Haider M.A., Gertner M.R., Bogaards A., Giewercer D., et al. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Physics in Medicine and Biology 2009, 54:2293-2313.
18. Berdugo M., Bejjani R.A., Valamanesh F., Savoldelli M., Jeanny J.C., Blanc D., et al. Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. Investigative Ophthalmology and Visual Science 2008, 49:1633-1644.
19. Szczygiel M., Urbanska K., Jurecka P., Stawoska I., Stochel G., Fiedor L. Central metal determines pharmacokinetics of chlorophyll-derived xenobiotics. Journal of Medicinal Chemistry 2008, 51:4412-4418.
20. Doyle L.A., Ross D.D. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 2003, 22:7340-7358.
21. Szakacs G., Paterson J.K., Ludwig J.A., Booth-Genthe C., Gottesman M.M. Targeting multidrug resistance in cancer. Nature Drug Discovery 2006, 5:219-234.
22. Fiedor L., Rosenbach-Belkin V., Scherz A. The stereospecific interaction between chlorophylls and chlorophyllase, possible implication for chlorophyll biosynthesis and degradation. Journal of Biological Chemistry 1992, 267:22043-22047.
23. Detty M.R., Gibson S.L., Wagner S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. Journal of Medicinal Chemistry 2004, 47:3897-3915.
24. Ball D.J., Mayhew S., Vernon D.I., Griffin M., Brown S.B. Decreased efficiency of trypsinization of cells following photodynamic therapy: evaluation of a role for tissue transglutaminase. Photochemistry and Photobiology 2001, 73:47-53.
25. Crissman H. Cell cycle analysis by flow cytometry. Cell growth and apoptosis 1995, 21-43. IRL Press, Oxford. G. Studzinski (Ed.).
26. Wyld L., Reed M.W., Brown N.J. Differential cell death response to photodynamic therapy is dependent on dose and cell type. British Journal of Cancer 2001, 84:1384-1386.
27. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Research 1997, 57:1835-1840.
28. Woodburn K.W., Vardaxis N.J., Hill J.S., Kaye A.H., Reiss J.A., Phillips D.R. Evaluation of porphyrin characteristics required for photodynamic therapy. Photochemistry and Photobiology 1992, 55:697-704.
29. Rosenbach-Belkin V., Chen L., Fiedor L., Tregub I., Pavlotsky F., Brumfeld V., et al. Serine conjugates of chlorophyll and bacteriochlorophyll: photocytotoxicity and tissue distribution in mice bearing melanoma tumors. Photochemistry and Photobiology 1996, 64:174-181.
30. MacDonald I.J., Morgan J., Bellnier D.A., Paszkiewicz G.M., Whitaker J.E., Litchfield D.J., et al. Subcellular localization patterns and their relationship to photodynamic activity of pyropheophorbide-a derivatives. Photochemistry and Photobiology 1999, 70:789-797.
31. Plaks V., Koudinova N., Nevo U., Pinthus J.H., Kanety H., Eshhar Z., et al. Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. Neoplasia 2004, 6:224-233.
32. Henderson B.W., Gollnick S.O., Snyder J.W., Busch T.M., Kousis P.C., Cheney R.T., et al. Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors. Cancer Research 2004, 64:2120-2126.
33. Dougherty T.J. An update on photodynamic therapy applications. Journal of Clinical Laser Medicine and Surgery 2002, 20:3-7.
34. Matroule J.Y., Bonizzi G., Morliere P., Paillous N., Santus R., Bours V., et al. Pyropheophorbide-a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. Journal of Biological Chemistry 1999, 274:2988-3000.
35. Berlanda J., Kiesslich T., Engelhardt V., Krammer B., Plaetzer K. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. Journal of Photochemistry and Photobiology B 2010, 100:173-180.
36. Nonaka T., Nanashima A., Nonaka M., Uehara M., Isomoto H., Asahina I., et al. Analysis of apoptotic effects induced by photodynamic therapy in a human biliary cancer cell line. Anticancer Research 2010, 30:2113-2118.
37. Saczko J., Chwilkowska A., Kulbacka J., Berdowska I., Zielinski B., Drag-Zalesinska M., et al. Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy. Folia Biologica 2008, 54:24-29.
38. Li L., Luo R., Liao W., Zhang M., Luo Y., Miao J. Clinical study of photofrin photodynamic therapy for the treatment of relapse nasopharyngeal carcinoma. Photodiagnosis and Photodynamic Therapy 2006, 3.
39. Wyss P., Schwarz V., Dobler-Girdziunaite D., Hornung R., Walt H., Degen A., et al. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer. International Journal of Cancer 2001, 93:720-724.
40. Fiedor L., Kania A., Mysliwa-Kurdziel B., Stochel G. Understanding chlorophylls: central magnesium and phytyl as structural determinants. Biochimica et Biophysica Acta 2008, 1777:1491-1500.
41. Brault D. Physical chemistry of porphyrins and their interactions with membranes: the importance of pH. Journal of Photochemistry and Photobiology B 1990, 6:79-86.
42. Al-Omari S. Photophysical properties and localization of chlorins substitutes with metoxy groups, hydroxyl groups and alkyl chains in liposome-like cellular membrane. Biomedicine Materials 2007, 2:107-115.
43. Ji Z., Yang G., Vasovic V., Cunderlikova B., Suo Z., Nesland J.M., et al. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines. Journal of Photochemistry and Photobiology B: Biology 2006, 84:213-220.
44. Sun X., Leung W. Photodynamic therapy with pyropheophorbide-a methyl ester in human lung carcinoma cancer cell: efficacy, localization and apoptosis. Photochemistry and Photobiology 2002, 75:644-651.
45. Bonnet R. Chemical aspects of photodynamic therapy 2000, Gordon and Breach Science Publishers, Amsterdam.
46. Kohen E., Santus R., Hirschberg J.G. Photobiology 1995, Academic Press, San Diego.
47. Mak N.-K., Li K.-M., Leung W.-N., Wong R.-S., Huang D., Lung M., et al. Involvement of both endoplasmic reticulum and mitochondria in photokilling of nasopharyngeal carcinoma cells by the photosensitizer Zn-BM-AM. Biochemical Pharmacology 2004, 68:2387-2396.
48. ® and caspase activation in photosensitized MCF-7 cells. British Journal of Cancer 2007, 96:944-951.
49. Oleinick N.L., Nieminen A.L., Chiu S.M. Cell killing by photodynamic therapy. Advances in photodynamic therapy 2008, 115-133. Artech House, Norwood, MA, USA. M.R. Hamblin, P. Mroz (Eds.).
50. Robaszkiewicz A., Balcerczyk A., Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biology International 2007, 31:1245-1250.
51. Shrivastava A., Tiwari M., Sinha R.A., Kumar A., Balapure A.K., Bajpai V.K., et al. Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. Journal of Biological Chemistry 2006, 281:19762-19771.
52. Watts M.E., Dennis M.F., Roberts I.J. Radiosensitization by misonidazole, pimonidazole and azomycin and intracellular uptake in human tumour cell lines. International Journal of Radiation Biology 1990, 57:361-372.
53. Kutala V.K., Parinandi N.L., Pandian R.P., Kuppusamy P. Simultaneous measurement of oxygenation in intracellular and extracellular compartments of lung microvascular endothelial cells. Antioxidants and Redox Signalling 2004, 6:597-603.
54. Subczynski W., Swartz H. EPR oxymetry in biological and model samples. Biomedical ESR - Part A: free radicals, metals, medicine, and physiology 2006, Vol. 23. Kluwer Academic Publishers, Boston.
55. Brandis A., Salomon Y., Scherz A. Bacteriochlorophyll sensitizers in photodynamic therapy. Chlorophylls and bacteriochlorophyls: biochemistry, biophysics, functions and applications 2006, 485-494. Springer, Dordrecht. B. Grimm, R. Porra, W. Rudiger, H. Scheer (Eds.).
56. Katsumi T.A., Aizawa K., Kuroiwa Y., Saito K., Kurata Y., Ii Y., et al. Photodynamic therapy with a diode laser for implanted fibrosarcoma in mice employing mono-l-aspartyl chlorin E6. Photochemistry and Photobiology 1996, 64:671-675.
57. Dabrowski J.M., Urbanska K., Arnaut L.G., Pereira M.M., Abreu A.R., Simoes S., et al. Biodistribution and photodynamic efficacy of a water-soluble, stable, halogenated bacteriochlorin against melanoma. ChemMedChem 2011, 6:465-475.
58. Mazor O., Brandis A., Plaks V., Neumark E., Rosenbach-Belkin V., Salomon Y., et al. WST11, a novel water-soluble bacteriochlorophyll derivative; cellular uptake, pharmacokinetics, biodistribution and vascular-targeted photodynamic activity using melanoma tumors as a model. Photochemistry and Photobiology 2005, 81:342-351.